Search Results - "amyloid"

Imaging amyloid now that we can see it, what does it all mean? /

Table of Contents: “…Contents: Amyloid imaging PET tracers -- Development and validation -- Amyloid imaging in dementia -- Amyloid imaging in mild cognitive impairment -- Amyloid imaging in cognitively normal elderly -- Consequences of being amyloid-positive.…”
Get full text
Series

Imaging amyloid now that we can see it, what does it all mean? /

Table of Contents: “…Contents: Amyloid imaging PET tracers -- Development and validation -- Amyloid imaging in dementia -- Amyloid imaging in mild cognitive impairment -- Amyloid imaging in cognitively normal elderly -- Consequences of being amyloid-positive.…”
Get full text
Series

Imaging amyloid now that we can see it, what does it all mean? /

Table of Contents: “…Contents: Amyloid imaging PET tracers -- Development and validation -- Amyloid imaging in dementia -- Amyloid imaging in mild cognitive impairment -- Amyloid imaging in cognitively normal elderly -- Consequences of being amyloid-positive.…”
Get full text
Series

Neuroimaging markers in AD trials

Table of Contents: “…Contents: Imaging in Alzheimer's Disease (AD) trials -- Increasing range of modalities to measure brain structure, function and molecular pathology of AD -- Early diagnosis, inclusion markers and measurement of progression -- MRI to measure atrophy -- PET to measure amyloid.…”
Get full text
Series

Neuroimaging markers in AD trials

Table of Contents: “…Contents: Imaging in Alzheimer's Disease (AD) trials -- Increasing range of modalities to measure brain structure, function and molecular pathology of AD -- Early diagnosis, inclusion markers and measurement of progression -- MRI to measure atrophy -- PET to measure amyloid.…”
Get full text
Series

Neuroimaging markers in AD trials

Table of Contents: “…Contents: Imaging in Alzheimer's Disease (AD) trials -- Increasing range of modalities to measure brain structure, function and molecular pathology of AD -- Early diagnosis, inclusion markers and measurement of progression -- MRI to measure atrophy -- PET to measure amyloid.…”
Get full text
Series